Table 4.
Pharmacological Therapy
| Controlled Blood Pressure (N = 64) | Post-Guidelines Uncontrolled Blood Pressure (N = 130) | Pre-Guidelines Uncontrolled Blood Pressure (N = 54) | P value | |
|---|---|---|---|---|
| Years diagnosed with hypertension (year), Mean (SD) | 8.1 (3.68) | 8.5 (4.99) | 7.3 (4.93) | 0.320 |
| Years taking anti-hypertensive drugs (year), Mean (SD) | 8 (3.78) | 8.4 (4.97) | 7.3 (4.93) | 0.325 |
| Class of current medications taken per day, Mean (SD) | 3.3 (1.62) | 3.0 (1.60) | 2.7 (1.38) | 0.166 |
| Types of anti-hypertensive drugs taken per day, | ||||
| Mean (SD) | 1.4 (0.64) | 1.4 (0.58) | 1.4 (0.56) | 0.775 |
| Median (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.861* |
| Number of times taking anti-hypertensive drugs, | ||||
| Mean (SD) | 1.8 (0.46) | 1.7 (0.52) | 1.7 (0.48) | 0.422 |
| Median (IQR) | 2 (2–2) | 2 (1–2) | 2 (1–2) | 0.414* |
| Types of current anti-hypertensive drug | ||||
| • Calcium channel blockers, n(col %) | 36 (56.25) | 74 (56.92) | 33 (61.11) | 0.842 |
| • ACEIs, n(col. %) | 11 (17.19) | 10 (7.69) | 5 (9.26) | 0.121 |
| • ARBs, n(col %) | 26 (40.63) | 70 (53.85) | 25 (46.30) | 0.205 |
| • Thiazide type, n(col %) | 3 (4.69) | 7 (5.38) | 4 (7.41) | 0.802 |
| • Beta blockers, n(col %) | 7 (10.94) | 13 (10.00) | 2 (3.70) | 0.312 |
| • Other, n(col %) | 2 (3.13) | 0 | 1 (1.85) | 0.514 |
| Combined drugs use, n(col. %) | 9 (14.06) | 13 (10.00) | 6 (11.11) | 0.702 |
| Experience of side effects from anti-hypertensive drugs, n(col %) | 6 (9.38) | 11 (8.46) | 8 (14.81) | 0.418 |
| High medication adherence, n(col %) | 32 (50.00) | 42 (32.31) | 14 (25.93) | 0.013 |
*Kruskal-Wallis rank test